Author:
Sharma Manish,Farough Samira,Burkett Andre,Prasanth Jerome,El-Shafeey Nabil,Zygadlo Dominic,Dunn Chera,Korn Ron
Reference19 articles.
1. Radiologists and Clinical Trials: Part 1 The Truth About Reader Disagreements
2. Guidance for Industry Developing Medical Imaging Drug and Biologic Products. Part 3: Design, Analysis, and Interpretation of Clinical Studies. US Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research. Center for Biologics Evaluation and Research; 2004.
3. Clinical Trial Imaging Endpoints Process Standards Guidance for Industry Draft US Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research. Center for Biologics Evaluation and Research. March 2015 Revision1.
4. Adjudication Rates between Readers in Blinded Independent Central Review of Oncology Studies;Ford;J Clin Trials,2016
5. Discrepancies of assessments in a RECIST 1.1 phase II clinical trial – association between adjudication rate and variability in images and tumors selection